Global Metabolomics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Metabolomics market size was valued at USD 2197.8 million in 2023 and is forecast to a readjusted size of USD 4964.5 million by 2030 with a CAGR of 12.3% during review period.
The key manufacturers of Metabolomics include Thermo Fisher, Agilent, Metabolon, Shimadzu, Corporation, Bruker, Waters Corporation, etc. Among them, Thermo Fisher and Agilent rank first and second in the world market share, about 12% and 9% respectively.
The market of metabolomics is distributed all over the world, with North America, Europe and Asia Pacific as the major markets. The North American market share reached more than 40%, ranking first in the world.
In terms of product, it include Metabolomics Instruments as well as Bioinformatics Tools and Services. The world market share of the two parts is about 2:1. It is expected that Bioinformatics Tools and Services' market share will increase relatively in the future.
Metabolomics is mainly used in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other institutional organizations. Among them, academic and research institutions occupy the highest market share, accounting for more than 45%. In the Chinese market, the share of academic and research institutions has reached more than 50%.
The Global Info Research report includes an overview of the development of the Metabolomics industry chain, the market status of Academic and Research Institutes (Metabolomics Instruments, Bioinformatics Tools and Services), Pharmaceutical and Biotechnology Companies (Metabolomics Instruments, Bioinformatics Tools and Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Metabolomics.
Regionally, the report analyzes the Metabolomics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Metabolomics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Metabolomics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Metabolomics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Metabolomics Instruments, Bioinformatics Tools and Services).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Metabolomics market.
Regional Analysis: The report involves examining the Metabolomics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Metabolomics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Metabolomics:
Company Analysis: Report covers individual Metabolomics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Metabolomics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies).
Technology Analysis: Report covers specific technologies relevant to Metabolomics. It assesses the current state, advancements, and potential future developments in Metabolomics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Metabolomics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Metabolomics market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.
Market segment by Type
Chapter 1, to describe Metabolomics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Metabolomics, with revenue, gross margin and global market share of Metabolomics from 2019 to 2024.
Chapter 3, the Metabolomics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Metabolomics market forecast, by regions, type and end user, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metabolomics.
Chapter 13, to describe Metabolomics research findings and conclusion.
The key manufacturers of Metabolomics include Thermo Fisher, Agilent, Metabolon, Shimadzu, Corporation, Bruker, Waters Corporation, etc. Among them, Thermo Fisher and Agilent rank first and second in the world market share, about 12% and 9% respectively.
The market of metabolomics is distributed all over the world, with North America, Europe and Asia Pacific as the major markets. The North American market share reached more than 40%, ranking first in the world.
In terms of product, it include Metabolomics Instruments as well as Bioinformatics Tools and Services. The world market share of the two parts is about 2:1. It is expected that Bioinformatics Tools and Services' market share will increase relatively in the future.
Metabolomics is mainly used in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other institutional organizations. Among them, academic and research institutions occupy the highest market share, accounting for more than 45%. In the Chinese market, the share of academic and research institutions has reached more than 50%.
The Global Info Research report includes an overview of the development of the Metabolomics industry chain, the market status of Academic and Research Institutes (Metabolomics Instruments, Bioinformatics Tools and Services), Pharmaceutical and Biotechnology Companies (Metabolomics Instruments, Bioinformatics Tools and Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Metabolomics.
Regionally, the report analyzes the Metabolomics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Metabolomics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Metabolomics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Metabolomics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Metabolomics Instruments, Bioinformatics Tools and Services).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Metabolomics market.
Regional Analysis: The report involves examining the Metabolomics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Metabolomics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Metabolomics:
Company Analysis: Report covers individual Metabolomics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Metabolomics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies).
Technology Analysis: Report covers specific technologies relevant to Metabolomics. It assesses the current state, advancements, and potential future developments in Metabolomics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Metabolomics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Metabolomics market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.
Market segment by Type
- Metabolomics Instruments
- Bioinformatics Tools and Services
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Thermo Fisher
- Agilent
- Metabolon
- Shimadzu Corporation
- Bruker
- Waters Corporation
- Biotree
- LECO Corporation
- Biocrates Life Sciences AG
- Human Metabolome Technologies
- Metware
- Applied Protein Technology
- Creative Proteomics
- Diagnostic Solutions Laboratory
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Metabolomics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Metabolomics, with revenue, gross margin and global market share of Metabolomics from 2019 to 2024.
Chapter 3, the Metabolomics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Metabolomics market forecast, by regions, type and end user, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metabolomics.
Chapter 13, to describe Metabolomics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Metabolomics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Metabolomics by Type
1.3.1 Overview: Global Metabolomics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Metabolomics Consumption Value Market Share by Type in 2023
1.3.3 Metabolomics Instruments
1.3.4 Bioinformatics Tools and Services
1.4 Global Metabolomics Market by End User
1.4.1 Overview: Global Metabolomics Market Size by End User: 2019 Versus 2023 Versus 2030
1.4.2 Academic and Research Institutes
1.4.3 Pharmaceutical and Biotechnology Companies
1.4.4 Contract Research Organizations
1.5 Global Metabolomics Market Size & Forecast
1.6 Global Metabolomics Market Size and Forecast by Region
1.6.1 Global Metabolomics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Metabolomics Market Size by Region, (2019-2030)
1.6.3 North America Metabolomics Market Size and Prospect (2019-2030)
1.6.4 Europe Metabolomics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Metabolomics Market Size and Prospect (2019-2030)
1.6.6 South America Metabolomics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Metabolomics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Metabolomics Product and Solutions
2.1.4 Thermo Fisher Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Agilent
2.2.1 Agilent Details
2.2.2 Agilent Major Business
2.2.3 Agilent Metabolomics Product and Solutions
2.2.4 Agilent Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Agilent Recent Developments and Future Plans
2.3 Metabolon
2.3.1 Metabolon Details
2.3.2 Metabolon Major Business
2.3.3 Metabolon Metabolomics Product and Solutions
2.3.4 Metabolon Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Metabolon Recent Developments and Future Plans
2.4 Shimadzu Corporation
2.4.1 Shimadzu Corporation Details
2.4.2 Shimadzu Corporation Major Business
2.4.3 Shimadzu Corporation Metabolomics Product and Solutions
2.4.4 Shimadzu Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shimadzu Corporation Recent Developments and Future Plans
2.5 Bruker
2.5.1 Bruker Details
2.5.2 Bruker Major Business
2.5.3 Bruker Metabolomics Product and Solutions
2.5.4 Bruker Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bruker Recent Developments and Future Plans
2.6 Waters Corporation
2.6.1 Waters Corporation Details
2.6.2 Waters Corporation Major Business
2.6.3 Waters Corporation Metabolomics Product and Solutions
2.6.4 Waters Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Waters Corporation Recent Developments and Future Plans
2.7 Biotree
2.7.1 Biotree Details
2.7.2 Biotree Major Business
2.7.3 Biotree Metabolomics Product and Solutions
2.7.4 Biotree Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotree Recent Developments and Future Plans
2.8 LECO Corporation
2.8.1 LECO Corporation Details
2.8.2 LECO Corporation Major Business
2.8.3 LECO Corporation Metabolomics Product and Solutions
2.8.4 LECO Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 LECO Corporation Recent Developments and Future Plans
2.9 Biocrates Life Sciences AG
2.9.1 Biocrates Life Sciences AG Details
2.9.2 Biocrates Life Sciences AG Major Business
2.9.3 Biocrates Life Sciences AG Metabolomics Product and Solutions
2.9.4 Biocrates Life Sciences AG Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.10 Human Metabolome Technologies
2.10.1 Human Metabolome Technologies Details
2.10.2 Human Metabolome Technologies Major Business
2.10.3 Human Metabolome Technologies Metabolomics Product and Solutions
2.10.4 Human Metabolome Technologies Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Human Metabolome Technologies Recent Developments and Future Plans
2.11 Metware
2.11.1 Metware Details
2.11.2 Metware Major Business
2.11.3 Metware Metabolomics Product and Solutions
2.11.4 Metware Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Metware Recent Developments and Future Plans
2.12 Applied Protein Technology
2.12.1 Applied Protein Technology Details
2.12.2 Applied Protein Technology Major Business
2.12.3 Applied Protein Technology Metabolomics Product and Solutions
2.12.4 Applied Protein Technology Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Applied Protein Technology Recent Developments and Future Plans
2.13 Creative Proteomics
2.13.1 Creative Proteomics Details
2.13.2 Creative Proteomics Major Business
2.13.3 Creative Proteomics Metabolomics Product and Solutions
2.13.4 Creative Proteomics Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Creative Proteomics Recent Developments and Future Plans
2.14 Diagnostic Solutions Laboratory
2.14.1 Diagnostic Solutions Laboratory Details
2.14.2 Diagnostic Solutions Laboratory Major Business
2.14.3 Diagnostic Solutions Laboratory Metabolomics Product and Solutions
2.14.4 Diagnostic Solutions Laboratory Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Diagnostic Solutions Laboratory Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Metabolomics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Metabolomics by Company Revenue
3.2.2 Top 3 Metabolomics Players Market Share in 2023
3.2.3 Top 6 Metabolomics Players Market Share in 2023
3.3 Metabolomics Market: Overall Company Footprint Analysis
3.3.1 Metabolomics Market: Region Footprint
3.3.2 Metabolomics Market: Company Product Type Footprint
3.3.3 Metabolomics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Metabolomics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Metabolomics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY END USER
5.1 Global Metabolomics Consumption Value Market Share by End User (2019-2024)
5.2 Global Metabolomics Market Forecast by End User (2025-2030)
6 NORTH AMERICA
6.1 North America Metabolomics Consumption Value by Type (2019-2030)
6.2 North America Metabolomics Consumption Value by End User (2019-2030)
6.3 North America Metabolomics Market Size by Country
6.3.1 North America Metabolomics Consumption Value by Country (2019-2030)
6.3.2 United States Metabolomics Market Size and Forecast (2019-2030)
6.3.3 Canada Metabolomics Market Size and Forecast (2019-2030)
6.3.4 Mexico Metabolomics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Metabolomics Consumption Value by Type (2019-2030)
7.2 Europe Metabolomics Consumption Value by End User (2019-2030)
7.3 Europe Metabolomics Market Size by Country
7.3.1 Europe Metabolomics Consumption Value by Country (2019-2030)
7.3.2 Germany Metabolomics Market Size and Forecast (2019-2030)
7.3.3 France Metabolomics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Metabolomics Market Size and Forecast (2019-2030)
7.3.5 Russia Metabolomics Market Size and Forecast (2019-2030)
7.3.6 Italy Metabolomics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Metabolomics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Metabolomics Consumption Value by End User (2019-2030)
8.3 Asia-Pacific Metabolomics Market Size by Region
8.3.1 Asia-Pacific Metabolomics Consumption Value by Region (2019-2030)
8.3.2 China Metabolomics Market Size and Forecast (2019-2030)
8.3.3 Japan Metabolomics Market Size and Forecast (2019-2030)
8.3.4 South Korea Metabolomics Market Size and Forecast (2019-2030)
8.3.5 India Metabolomics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Metabolomics Market Size and Forecast (2019-2030)
8.3.7 Australia Metabolomics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Metabolomics Consumption Value by Type (2019-2030)
9.2 South America Metabolomics Consumption Value by End User (2019-2030)
9.3 South America Metabolomics Market Size by Country
9.3.1 South America Metabolomics Consumption Value by Country (2019-2030)
9.3.2 Brazil Metabolomics Market Size and Forecast (2019-2030)
9.3.3 Argentina Metabolomics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Metabolomics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Metabolomics Consumption Value by End User (2019-2030)
10.3 Middle East & Africa Metabolomics Market Size by Country
10.3.1 Middle East & Africa Metabolomics Consumption Value by Country (2019-2030)
10.3.2 Turkey Metabolomics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Metabolomics Market Size and Forecast (2019-2030)
10.3.4 UAE Metabolomics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Metabolomics Market Drivers
11.2 Metabolomics Market Restraints
11.3 Metabolomics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Metabolomics Industry Chain
12.2 Metabolomics Upstream Analysis
12.3 Metabolomics Midstream Analysis
12.4 Metabolomics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Metabolomics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Metabolomics by Type
1.3.1 Overview: Global Metabolomics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Metabolomics Consumption Value Market Share by Type in 2023
1.3.3 Metabolomics Instruments
1.3.4 Bioinformatics Tools and Services
1.4 Global Metabolomics Market by End User
1.4.1 Overview: Global Metabolomics Market Size by End User: 2019 Versus 2023 Versus 2030
1.4.2 Academic and Research Institutes
1.4.3 Pharmaceutical and Biotechnology Companies
1.4.4 Contract Research Organizations
1.5 Global Metabolomics Market Size & Forecast
1.6 Global Metabolomics Market Size and Forecast by Region
1.6.1 Global Metabolomics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Metabolomics Market Size by Region, (2019-2030)
1.6.3 North America Metabolomics Market Size and Prospect (2019-2030)
1.6.4 Europe Metabolomics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Metabolomics Market Size and Prospect (2019-2030)
1.6.6 South America Metabolomics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Metabolomics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Metabolomics Product and Solutions
2.1.4 Thermo Fisher Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Agilent
2.2.1 Agilent Details
2.2.2 Agilent Major Business
2.2.3 Agilent Metabolomics Product and Solutions
2.2.4 Agilent Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Agilent Recent Developments and Future Plans
2.3 Metabolon
2.3.1 Metabolon Details
2.3.2 Metabolon Major Business
2.3.3 Metabolon Metabolomics Product and Solutions
2.3.4 Metabolon Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Metabolon Recent Developments and Future Plans
2.4 Shimadzu Corporation
2.4.1 Shimadzu Corporation Details
2.4.2 Shimadzu Corporation Major Business
2.4.3 Shimadzu Corporation Metabolomics Product and Solutions
2.4.4 Shimadzu Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shimadzu Corporation Recent Developments and Future Plans
2.5 Bruker
2.5.1 Bruker Details
2.5.2 Bruker Major Business
2.5.3 Bruker Metabolomics Product and Solutions
2.5.4 Bruker Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bruker Recent Developments and Future Plans
2.6 Waters Corporation
2.6.1 Waters Corporation Details
2.6.2 Waters Corporation Major Business
2.6.3 Waters Corporation Metabolomics Product and Solutions
2.6.4 Waters Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Waters Corporation Recent Developments and Future Plans
2.7 Biotree
2.7.1 Biotree Details
2.7.2 Biotree Major Business
2.7.3 Biotree Metabolomics Product and Solutions
2.7.4 Biotree Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotree Recent Developments and Future Plans
2.8 LECO Corporation
2.8.1 LECO Corporation Details
2.8.2 LECO Corporation Major Business
2.8.3 LECO Corporation Metabolomics Product and Solutions
2.8.4 LECO Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 LECO Corporation Recent Developments and Future Plans
2.9 Biocrates Life Sciences AG
2.9.1 Biocrates Life Sciences AG Details
2.9.2 Biocrates Life Sciences AG Major Business
2.9.3 Biocrates Life Sciences AG Metabolomics Product and Solutions
2.9.4 Biocrates Life Sciences AG Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.10 Human Metabolome Technologies
2.10.1 Human Metabolome Technologies Details
2.10.2 Human Metabolome Technologies Major Business
2.10.3 Human Metabolome Technologies Metabolomics Product and Solutions
2.10.4 Human Metabolome Technologies Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Human Metabolome Technologies Recent Developments and Future Plans
2.11 Metware
2.11.1 Metware Details
2.11.2 Metware Major Business
2.11.3 Metware Metabolomics Product and Solutions
2.11.4 Metware Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Metware Recent Developments and Future Plans
2.12 Applied Protein Technology
2.12.1 Applied Protein Technology Details
2.12.2 Applied Protein Technology Major Business
2.12.3 Applied Protein Technology Metabolomics Product and Solutions
2.12.4 Applied Protein Technology Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Applied Protein Technology Recent Developments and Future Plans
2.13 Creative Proteomics
2.13.1 Creative Proteomics Details
2.13.2 Creative Proteomics Major Business
2.13.3 Creative Proteomics Metabolomics Product and Solutions
2.13.4 Creative Proteomics Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Creative Proteomics Recent Developments and Future Plans
2.14 Diagnostic Solutions Laboratory
2.14.1 Diagnostic Solutions Laboratory Details
2.14.2 Diagnostic Solutions Laboratory Major Business
2.14.3 Diagnostic Solutions Laboratory Metabolomics Product and Solutions
2.14.4 Diagnostic Solutions Laboratory Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Diagnostic Solutions Laboratory Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Metabolomics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Metabolomics by Company Revenue
3.2.2 Top 3 Metabolomics Players Market Share in 2023
3.2.3 Top 6 Metabolomics Players Market Share in 2023
3.3 Metabolomics Market: Overall Company Footprint Analysis
3.3.1 Metabolomics Market: Region Footprint
3.3.2 Metabolomics Market: Company Product Type Footprint
3.3.3 Metabolomics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Metabolomics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Metabolomics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY END USER
5.1 Global Metabolomics Consumption Value Market Share by End User (2019-2024)
5.2 Global Metabolomics Market Forecast by End User (2025-2030)
6 NORTH AMERICA
6.1 North America Metabolomics Consumption Value by Type (2019-2030)
6.2 North America Metabolomics Consumption Value by End User (2019-2030)
6.3 North America Metabolomics Market Size by Country
6.3.1 North America Metabolomics Consumption Value by Country (2019-2030)
6.3.2 United States Metabolomics Market Size and Forecast (2019-2030)
6.3.3 Canada Metabolomics Market Size and Forecast (2019-2030)
6.3.4 Mexico Metabolomics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Metabolomics Consumption Value by Type (2019-2030)
7.2 Europe Metabolomics Consumption Value by End User (2019-2030)
7.3 Europe Metabolomics Market Size by Country
7.3.1 Europe Metabolomics Consumption Value by Country (2019-2030)
7.3.2 Germany Metabolomics Market Size and Forecast (2019-2030)
7.3.3 France Metabolomics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Metabolomics Market Size and Forecast (2019-2030)
7.3.5 Russia Metabolomics Market Size and Forecast (2019-2030)
7.3.6 Italy Metabolomics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Metabolomics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Metabolomics Consumption Value by End User (2019-2030)
8.3 Asia-Pacific Metabolomics Market Size by Region
8.3.1 Asia-Pacific Metabolomics Consumption Value by Region (2019-2030)
8.3.2 China Metabolomics Market Size and Forecast (2019-2030)
8.3.3 Japan Metabolomics Market Size and Forecast (2019-2030)
8.3.4 South Korea Metabolomics Market Size and Forecast (2019-2030)
8.3.5 India Metabolomics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Metabolomics Market Size and Forecast (2019-2030)
8.3.7 Australia Metabolomics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Metabolomics Consumption Value by Type (2019-2030)
9.2 South America Metabolomics Consumption Value by End User (2019-2030)
9.3 South America Metabolomics Market Size by Country
9.3.1 South America Metabolomics Consumption Value by Country (2019-2030)
9.3.2 Brazil Metabolomics Market Size and Forecast (2019-2030)
9.3.3 Argentina Metabolomics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Metabolomics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Metabolomics Consumption Value by End User (2019-2030)
10.3 Middle East & Africa Metabolomics Market Size by Country
10.3.1 Middle East & Africa Metabolomics Consumption Value by Country (2019-2030)
10.3.2 Turkey Metabolomics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Metabolomics Market Size and Forecast (2019-2030)
10.3.4 UAE Metabolomics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Metabolomics Market Drivers
11.2 Metabolomics Market Restraints
11.3 Metabolomics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Metabolomics Industry Chain
12.2 Metabolomics Upstream Analysis
12.3 Metabolomics Midstream Analysis
12.4 Metabolomics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Metabolomics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Metabolomics Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Table 3. Global Metabolomics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Metabolomics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Major Business
Table 7. Thermo Fisher Metabolomics Product and Solutions
Table 8. Thermo Fisher Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Thermo Fisher Recent Developments and Future Plans
Table 10. Agilent Company Information, Head Office, and Major Competitors
Table 11. Agilent Major Business
Table 12. Agilent Metabolomics Product and Solutions
Table 13. Agilent Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Agilent Recent Developments and Future Plans
Table 15. Metabolon Company Information, Head Office, and Major Competitors
Table 16. Metabolon Major Business
Table 17. Metabolon Metabolomics Product and Solutions
Table 18. Metabolon Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Metabolon Recent Developments and Future Plans
Table 20. Shimadzu Corporation Company Information, Head Office, and Major Competitors
Table 21. Shimadzu Corporation Major Business
Table 22. Shimadzu Corporation Metabolomics Product and Solutions
Table 23. Shimadzu Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shimadzu Corporation Recent Developments and Future Plans
Table 25. Bruker Company Information, Head Office, and Major Competitors
Table 26. Bruker Major Business
Table 27. Bruker Metabolomics Product and Solutions
Table 28. Bruker Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bruker Recent Developments and Future Plans
Table 30. Waters Corporation Company Information, Head Office, and Major Competitors
Table 31. Waters Corporation Major Business
Table 32. Waters Corporation Metabolomics Product and Solutions
Table 33. Waters Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Waters Corporation Recent Developments and Future Plans
Table 35. Biotree Company Information, Head Office, and Major Competitors
Table 36. Biotree Major Business
Table 37. Biotree Metabolomics Product and Solutions
Table 38. Biotree Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Biotree Recent Developments and Future Plans
Table 40. LECO Corporation Company Information, Head Office, and Major Competitors
Table 41. LECO Corporation Major Business
Table 42. LECO Corporation Metabolomics Product and Solutions
Table 43. LECO Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. LECO Corporation Recent Developments and Future Plans
Table 45. Biocrates Life Sciences AG Company Information, Head Office, and Major Competitors
Table 46. Biocrates Life Sciences AG Major Business
Table 47. Biocrates Life Sciences AG Metabolomics Product and Solutions
Table 48. Biocrates Life Sciences AG Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Biocrates Life Sciences AG Recent Developments and Future Plans
Table 50. Human Metabolome Technologies Company Information, Head Office, and Major Competitors
Table 51. Human Metabolome Technologies Major Business
Table 52. Human Metabolome Technologies Metabolomics Product and Solutions
Table 53. Human Metabolome Technologies Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Human Metabolome Technologies Recent Developments and Future Plans
Table 55. Metware Company Information, Head Office, and Major Competitors
Table 56. Metware Major Business
Table 57. Metware Metabolomics Product and Solutions
Table 58. Metware Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Metware Recent Developments and Future Plans
Table 60. Applied Protein Technology Company Information, Head Office, and Major Competitors
Table 61. Applied Protein Technology Major Business
Table 62. Applied Protein Technology Metabolomics Product and Solutions
Table 63. Applied Protein Technology Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Applied Protein Technology Recent Developments and Future Plans
Table 65. Creative Proteomics Company Information, Head Office, and Major Competitors
Table 66. Creative Proteomics Major Business
Table 67. Creative Proteomics Metabolomics Product and Solutions
Table 68. Creative Proteomics Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Creative Proteomics Recent Developments and Future Plans
Table 70. Diagnostic Solutions Laboratory Company Information, Head Office, and Major Competitors
Table 71. Diagnostic Solutions Laboratory Major Business
Table 72. Diagnostic Solutions Laboratory Metabolomics Product and Solutions
Table 73. Diagnostic Solutions Laboratory Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Diagnostic Solutions Laboratory Recent Developments and Future Plans
Table 75. Global Metabolomics Revenue (USD Million) by Players (2019-2024)
Table 76. Global Metabolomics Revenue Share by Players (2019-2024)
Table 77. Breakdown of Metabolomics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Metabolomics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Metabolomics Players
Table 80. Metabolomics Market: Company Product Type Footprint
Table 81. Metabolomics Market: Company Product Application Footprint
Table 82. Metabolomics New Market Entrants and Barriers to Market Entry
Table 83. Metabolomics Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Metabolomics Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Metabolomics Consumption Value Share by Type (2019-2024)
Table 86. Global Metabolomics Consumption Value Forecast by Type (2025-2030)
Table 87. Global Metabolomics Consumption Value by End User (2019-2024)
Table 88. Global Metabolomics Consumption Value Forecast by End User (2025-2030)
Table 89. North America Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 92. North America Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 93. North America Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 98. Europe Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 99. Europe Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 104. Asia-Pacific Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 105. Asia-Pacific Metabolomics Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Metabolomics Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 110. South America Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 111. South America Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 116. Middle East & Africa Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 117. Middle East & Africa Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Metabolomics Raw Material
Table 120. Key Suppliers of Metabolomics Raw Materials
Table 1. Global Metabolomics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Metabolomics Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Table 3. Global Metabolomics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Metabolomics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Major Business
Table 7. Thermo Fisher Metabolomics Product and Solutions
Table 8. Thermo Fisher Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Thermo Fisher Recent Developments and Future Plans
Table 10. Agilent Company Information, Head Office, and Major Competitors
Table 11. Agilent Major Business
Table 12. Agilent Metabolomics Product and Solutions
Table 13. Agilent Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Agilent Recent Developments and Future Plans
Table 15. Metabolon Company Information, Head Office, and Major Competitors
Table 16. Metabolon Major Business
Table 17. Metabolon Metabolomics Product and Solutions
Table 18. Metabolon Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Metabolon Recent Developments and Future Plans
Table 20. Shimadzu Corporation Company Information, Head Office, and Major Competitors
Table 21. Shimadzu Corporation Major Business
Table 22. Shimadzu Corporation Metabolomics Product and Solutions
Table 23. Shimadzu Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shimadzu Corporation Recent Developments and Future Plans
Table 25. Bruker Company Information, Head Office, and Major Competitors
Table 26. Bruker Major Business
Table 27. Bruker Metabolomics Product and Solutions
Table 28. Bruker Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bruker Recent Developments and Future Plans
Table 30. Waters Corporation Company Information, Head Office, and Major Competitors
Table 31. Waters Corporation Major Business
Table 32. Waters Corporation Metabolomics Product and Solutions
Table 33. Waters Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Waters Corporation Recent Developments and Future Plans
Table 35. Biotree Company Information, Head Office, and Major Competitors
Table 36. Biotree Major Business
Table 37. Biotree Metabolomics Product and Solutions
Table 38. Biotree Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Biotree Recent Developments and Future Plans
Table 40. LECO Corporation Company Information, Head Office, and Major Competitors
Table 41. LECO Corporation Major Business
Table 42. LECO Corporation Metabolomics Product and Solutions
Table 43. LECO Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. LECO Corporation Recent Developments and Future Plans
Table 45. Biocrates Life Sciences AG Company Information, Head Office, and Major Competitors
Table 46. Biocrates Life Sciences AG Major Business
Table 47. Biocrates Life Sciences AG Metabolomics Product and Solutions
Table 48. Biocrates Life Sciences AG Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Biocrates Life Sciences AG Recent Developments and Future Plans
Table 50. Human Metabolome Technologies Company Information, Head Office, and Major Competitors
Table 51. Human Metabolome Technologies Major Business
Table 52. Human Metabolome Technologies Metabolomics Product and Solutions
Table 53. Human Metabolome Technologies Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Human Metabolome Technologies Recent Developments and Future Plans
Table 55. Metware Company Information, Head Office, and Major Competitors
Table 56. Metware Major Business
Table 57. Metware Metabolomics Product and Solutions
Table 58. Metware Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Metware Recent Developments and Future Plans
Table 60. Applied Protein Technology Company Information, Head Office, and Major Competitors
Table 61. Applied Protein Technology Major Business
Table 62. Applied Protein Technology Metabolomics Product and Solutions
Table 63. Applied Protein Technology Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Applied Protein Technology Recent Developments and Future Plans
Table 65. Creative Proteomics Company Information, Head Office, and Major Competitors
Table 66. Creative Proteomics Major Business
Table 67. Creative Proteomics Metabolomics Product and Solutions
Table 68. Creative Proteomics Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Creative Proteomics Recent Developments and Future Plans
Table 70. Diagnostic Solutions Laboratory Company Information, Head Office, and Major Competitors
Table 71. Diagnostic Solutions Laboratory Major Business
Table 72. Diagnostic Solutions Laboratory Metabolomics Product and Solutions
Table 73. Diagnostic Solutions Laboratory Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Diagnostic Solutions Laboratory Recent Developments and Future Plans
Table 75. Global Metabolomics Revenue (USD Million) by Players (2019-2024)
Table 76. Global Metabolomics Revenue Share by Players (2019-2024)
Table 77. Breakdown of Metabolomics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Metabolomics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Metabolomics Players
Table 80. Metabolomics Market: Company Product Type Footprint
Table 81. Metabolomics Market: Company Product Application Footprint
Table 82. Metabolomics New Market Entrants and Barriers to Market Entry
Table 83. Metabolomics Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Metabolomics Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Metabolomics Consumption Value Share by Type (2019-2024)
Table 86. Global Metabolomics Consumption Value Forecast by Type (2025-2030)
Table 87. Global Metabolomics Consumption Value by End User (2019-2024)
Table 88. Global Metabolomics Consumption Value Forecast by End User (2025-2030)
Table 89. North America Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 92. North America Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 93. North America Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 98. Europe Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 99. Europe Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 104. Asia-Pacific Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 105. Asia-Pacific Metabolomics Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Metabolomics Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 110. South America Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 111. South America Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Metabolomics Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Metabolomics Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Metabolomics Consumption Value by End User (2019-2024) & (USD Million)
Table 116. Middle East & Africa Metabolomics Consumption Value by End User (2025-2030) & (USD Million)
Table 117. Middle East & Africa Metabolomics Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Metabolomics Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Metabolomics Raw Material
Table 120. Key Suppliers of Metabolomics Raw Materials
LIST OF FIGURES
Figure 1. Metabolomics Picture
Figure 2. Global Metabolomics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Metabolomics Consumption Value Market Share by Type in 2023
Figure 4. Metabolomics Instruments
Figure 5. Bioinformatics Tools and Services
Figure 6. Global Metabolomics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Metabolomics Consumption Value Market Share by End User in 2023
Figure 8. Academic and Research Institutes Picture
Figure 9. Pharmaceutical and Biotechnology Companies Picture
Figure 10. Contract Research Organizations Picture
Figure 11. Global Metabolomics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Metabolomics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Metabolomics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Metabolomics Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Metabolomics Consumption Value Market Share by Region in 2023
Figure 16. North America Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Metabolomics Revenue Share by Players in 2023
Figure 22. Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Metabolomics Market Share in 2023
Figure 24. Global Top 6 Players Metabolomics Market Share in 2023
Figure 25. Global Metabolomics Consumption Value Share by Type (2019-2024)
Figure 26. Global Metabolomics Market Share Forecast by Type (2025-2030)
Figure 27. Global Metabolomics Consumption Value Share by End User (2019-2024)
Figure 28. Global Metabolomics Market Share Forecast by End User (2025-2030)
Figure 29. North America Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 31. North America Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 37. Europe Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 39. France Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 45. Asia-Pacific Metabolomics Consumption Value Market Share by Region (2019-2030)
Figure 46. China Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 49. India Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 54. South America Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 59. Middle East and Africa Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 63. Metabolomics Market Drivers
Figure 64. Metabolomics Market Restraints
Figure 65. Metabolomics Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Metabolomics in 2023
Figure 68. Manufacturing Process Analysis of Metabolomics
Figure 69. Metabolomics Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Metabolomics Picture
Figure 2. Global Metabolomics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Metabolomics Consumption Value Market Share by Type in 2023
Figure 4. Metabolomics Instruments
Figure 5. Bioinformatics Tools and Services
Figure 6. Global Metabolomics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Metabolomics Consumption Value Market Share by End User in 2023
Figure 8. Academic and Research Institutes Picture
Figure 9. Pharmaceutical and Biotechnology Companies Picture
Figure 10. Contract Research Organizations Picture
Figure 11. Global Metabolomics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Metabolomics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Metabolomics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Metabolomics Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Metabolomics Consumption Value Market Share by Region in 2023
Figure 16. North America Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Metabolomics Revenue Share by Players in 2023
Figure 22. Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Metabolomics Market Share in 2023
Figure 24. Global Top 6 Players Metabolomics Market Share in 2023
Figure 25. Global Metabolomics Consumption Value Share by Type (2019-2024)
Figure 26. Global Metabolomics Market Share Forecast by Type (2025-2030)
Figure 27. Global Metabolomics Consumption Value Share by End User (2019-2024)
Figure 28. Global Metabolomics Market Share Forecast by End User (2025-2030)
Figure 29. North America Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 31. North America Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 37. Europe Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 39. France Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 45. Asia-Pacific Metabolomics Consumption Value Market Share by Region (2019-2030)
Figure 46. China Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 49. India Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 54. South America Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Metabolomics Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Metabolomics Consumption Value Market Share by End User (2019-2030)
Figure 59. Middle East and Africa Metabolomics Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Metabolomics Consumption Value (2019-2030) & (USD Million)
Figure 63. Metabolomics Market Drivers
Figure 64. Metabolomics Market Restraints
Figure 65. Metabolomics Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Metabolomics in 2023
Figure 68. Manufacturing Process Analysis of Metabolomics
Figure 69. Metabolomics Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
